May 23, 2019

PAH-HOPE CSO Prof. Therese Kinsella is in Brussels meeting fellow entrepreneurs in the EIC community at SME Phase 2 Coordinators Welcome Day.

May 2, 2019

ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council Funding Opportunities for Breakthrough Innovation. This event is hosted by the European Commission Representation in Ireland and will take...

May 2, 2019

ATXA Therapeutics Ltd is proud to be listed among the 10 interesting Irish life sciences start-ups to watch. New hope for the PAH patient. #PAH_hope

May 1, 2019

ATXA Therapeutics Ltd CEO Dr Ivan Coulter on keeping up with the competition in the pharma space as featured in today's Leaders' Insight column in Silicon Republic


April 8, 2019

The ATXA Therapeutics team is looking forward to attending the MedTech Strategist Innovation Summit Dublin 2019. 1 more day to go !
This forum explores the needs, opportunities and challenges facing the global medical device industry.
#lifescience #invest #medicaldevic...

March 14, 2019

ATXA Therapeutics is attending BioCapital Europe in Amterdam today.
#Lifesciences #investment 

February 28, 2019

Today is Rare Disease Day 2019. #ShowYourRare. The aim is to raise awareness about rare diseases.

ATXA is on a mission to offer new hope to the PAH Patient. #PAH_Hope. PAH is a rare, progressive disorder.


February 25, 2019

ATXA is attending the Sachs Associates 12th Annual European Life Sciences CEO Conference at the Hilton Airport Zurich Hotel

Please reload

Recent Posts

September 30, 2019

Please reload